Sulfequine 333 mg/g + 67 mg/g oral paste for horses
Sulfequine 333 mg/g + 67 mg/g oral paste for horses
Authorised
- Sulfadiazine
- Trimethoprim
Product identification
Medicine name:
Sulfequine 333 mg/g + 67 mg/g oral paste for horses
SULFEQUINE 333 MG/G + 67 MG/G PATE ORALE POUR CHEVAUX
Active substance:
- Sulfadiazine
- Trimethoprim
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Sulfadiazine333.00milligram(s)1.00gram(s)
-
Trimethoprim67.00milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal15dayFor a treatment period of up to 5 days
-
Meat and offal6monthFor a treatment period of more than 5 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01EW10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Cardboard box containing 1 oral syringe containing 45 grams paste
- Cardboard box containing 5 oral syringes containing 45 grams paste
- Cardboard box containing 6 oral syringes containing 45 grams paste
- Cardboard box containing 10 oral syringes containing 45 grams paste
- Cardboard box containing 1 oral syringe containing 52.5 grams paste
- Cardboard box containing 5 oral syringes containing 52.5 grams paste
- Cardboard box containing 6 oral strings containing 52.5 grams paste
- Cardboard box containing 10 oral syringes containing 52.5 grams paste
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 19(1) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
- CP-Pharma Handelsgesellschaft mbH
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/7364950 2/2025
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0428/001/DC
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 18/07/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 18/07/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 18/07/2025
How useful was this page?: